Proxy Season 2018 Preview

 

Amy Borrus is deputy director of the Council of Institutional Investors (CII), a nonprofit, nonpartisan U.S. association of employee benefit funds, state and local entities charged with investing public assets, foundations and endowments, with combined assets in excess of $3 trillion, that promotes good corporate governance and strong shareholder rights. CII’s associate members include a range of asset managers with more than $20 trillion in assets under management. Amy plays a lead role in developing CII strategy, policies on corporate governance and other issues and outreach to stakeholders and policymakers. She manages CII communications and speaks frequently on behalf of CII.

 

Blair Jones works with Board Compensation Committees to align executive compensation with the unique business, market, and talent characteristics of the company ensuring value to executives is balanced by value to the company and its shareholders. Her insights and expertise are informed by 25 years of experience helping companies improve their business performance. She has worked extensively across industries, including healthcare, retail, professional services and consumer products, and has particular depth of expertise working with companies in transitional stages.

 

Scott H. Kimpel is a partner in the capital markets practice of Hunton & Williams LLP, resident in the Firm’s Washington DC office. He regularly advises clients across a broad sector of the economy facing sensitive reporting, compliance and enforcement matters before the Securities and Exchange Commission and other capital markets regulators. Scott’s practice encompasses a wide range of matters involving the securities laws, mergers and acquisitions, corporate governance, regulatory enforcement, administrative law and public policy. Before joining Hunton & Williams, Scott served on the Executive Staff of the SEC as Counsel to Commissioner Troy A. Paredes from 2008 to 2012.

 

Suzanne Rolon is Director, Corporate Governance at Pfizer where she is responsible for engaging with investors and other stakeholders on current and emerging governance issues. She is also responsible for overseeing all communications directed to the Board of Directors and managing the shareholder services function. She works as a member of the proxy development team and engages in negotiations with shareholder proponents and investors during the proxy season. Prior to Pfizer, Ms. Rolon worked for Delta Air Lines where she held positions in Investor Relations and Reservations Sales Training and Development. She is a member of the Society for Corporate Governance, the Council of Institutional Investors, and she serves on Computershare’s Client Advisory Board.